Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Endocr Relat Cancer. 2015 May 15;22(4):519–530. doi: 10.1530/ERC-15-0134

Table 4.

Presence of mutations, nsSNV or significant associated in each of the 16 tumor samples run through SOLiD

Novel PDE1C PDE2A PDE4A PDE4B PDE4C PDE5A PDE6A PDE6B PDE6C PDE7A PDE8A PDE8B PDE11A
DT01 @rs115957738 @rs577536
@rs11824084
#rs114886951 *rs115775983 *rs701865 #rs79903863
@rs75461311
DT02 @rs4944557
@rs392818
*rs2229228 @rs193276411
*rs701865
@rs75461311
DT03 PDE6C @rs76290787
@rs78021925
@rs11824084 @rs114408173 *rs2229228 *rs701865 @rs75461311
DT04 *rs1051738
DT07 PDE10A
PDE7B
@rs4944557 *rs2229228 *rs701865 *rs115599001 #rs79903863
DT08 *rs2229228 *rs701865 *rs115599001 #rs79903863
*rs75672043
DT10 *rs2229228 *rs701865 *rs11557049 *rs115599001 @rs75461311
*rs77597060
DT12 PDE10A *rs75398902 *rs2229228 *rs17400325
DT18 #rs3733526 *rs701865
DT19 PDE4B #rs76999928
DT21 *rs61736729 *rs2229228 #rs3733526
*rs17051276
*rs701865 *rs75127279
DT22 *rs1051738 #rs3733526 *rs701865 *rs11557049
DT32 *rs2229228 *rs701865
DT35 @rs577536 *rs701865 @rs148254104
DT38 @rs116449276 @rs34492439
@rs7534999
*rs2229228 @rs113309832 @rs73058408
@rs61734864
*rs11557049
DT45 PDE10A @rs116449276
*rs61745829
*rs1051738 *rs2229228 #rs3733526
*rs17051276
*rs115775983 *rs45522236
*rs701865
@rs182775622 *rs75672043
*rs17400325
*

Nonsynonymous SNV

#

Significant and nonsynonymous SNV

@

Significant synonymous or intronic SNV.